Literature DB >> 2413070

Concomitant detection of changes in myelin basic protein and permeability of blood-spinal cord barrier in acute experimental autoimmune encephalomyelitis by electroimmunoblotting.

N Kerlero de Rosbo, C C Bernard, R D Simmons, P R Carnegie.   

Abstract

An electroimmunoblotting technique was used with a monoclonal antibody to myelin basic protein (MBP) to assess demyelination in 3 defined regions of the spinal cord in rats with acute experimental autoimmune encephalomyelitis (EAE). A slight loss in MBP was detected only in the sacrococcygeal region of the spinal cord after the onset of clinical signs. In all 3 spinal cord regions studied, significantly elevated levels of albumin and IgG were detected during the course of EAE by the same technique. At the onset of clinical signs, the levels of IgG and albumin were highest in the more caudal regions of the spinal cord. As the clinical signs became more severe, IgG and albumin levels increased in the more cranial regions of the spinal cord. These changes thus correlated with the ascending progression of clinical signs typical of EAE in rats. These results provided added evidence that in rats affected with acute EAE, the clinical signs occur independently of demyelination and coincide with vasogenic edema.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2413070     DOI: 10.1016/s0165-5728(85)80035-7

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  12 in total

1.  Effect of lymphocytic infiltration on the blood-retinal barrier in experimental autoimmune uveoretinitis.

Authors:  S Lightman; J Greenwood
Journal:  Clin Exp Immunol       Date:  1992-06       Impact factor: 4.330

2.  Loss of blood-brain barrier integrity in the spinal cord is common to experimental allergic encephalomyelitis in knockout mouse models.

Authors:  Marzena J Fabis; Gwen S Scott; Rhonda B Kean; Hilary Koprowski; D Craig Hooper
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-19       Impact factor: 11.205

3.  Immunohistochemical localisation of terminal complement component C9 in experimental allergic encephalomyelitis.

Authors:  C Linington; H Lassmann; B P Morgan; D A Compston
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

4.  Viruses can silently prime for and trigger central nervous system autoimmune disease.

Authors:  D J Theil; I Tsunoda; F Rodriguez; J L Whitton; R S Fujinami
Journal:  J Neurovirol       Date:  2001-06       Impact factor: 2.643

5.  Increased vesicular transport and decreased mitochondrial content in blood-brain barrier endothelial cells during experimental autoimmune encephalomyelitis.

Authors:  L Claudio; Y Kress; W T Norton; C F Brosnan
Journal:  Am J Pathol       Date:  1989-12       Impact factor: 4.307

6.  Cerebellar susceptibility to experimental autoimmune encephalomyelitis in SJL/J mice: potential interaction of immunology with vascular anatomy.

Authors:  James R Tonra
Journal:  Cerebellum       Date:  2002 Jan-Mar       Impact factor: 3.847

7.  Leuprolide acetate, a GnRH agonist, improves experimental autoimmune encephalomyelitis: a possible therapy for multiple sclerosis.

Authors:  Irene Guzmán-Soto; Eva Salinas; Irma Hernández-Jasso; J Luis Quintanar
Journal:  Neurochem Res       Date:  2012-07-26       Impact factor: 3.996

8.  Macrophages in T cell line-mediated, demyelinating, and chronic relapsing experimental autoimmune encephalomyelitis in Lewis rats.

Authors:  I Huitinga; S R Ruuls; S Jung; N Van Rooijen; H P Hartung; C D Dijkstra
Journal:  Clin Exp Immunol       Date:  1995-05       Impact factor: 4.330

9.  Estrogen receptor-1 (Esr1) and -2 (Esr2) regulate the severity of clinical experimental allergic encephalomyelitis in male mice.

Authors:  Magdalena Polanczyk; Srikanth Yellayi; Alex Zamora; Sandhya Subramanian; Micah Tovey; Arthur A Vandenbark; Halina Offner; James F Zachary; Parley D Fillmore; Elizabeth P Blankenhorn; Jan-Ake Gustafsson; Cory Teuscher
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

Review 10.  Albumin and multiple sclerosis.

Authors:  Steven M LeVine
Journal:  BMC Neurol       Date:  2016-04-12       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.